These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
530 related items for PubMed ID: 31706322
1. Necroptosis regulates tumor repopulation after radiotherapy via RIP1/RIP3/MLKL/JNK/IL8 pathway. Wang Y, Zhao M, He S, Luo Y, Zhao Y, Cheng J, Gong Y, Xie J, Wang Y, Hu B, Tian L, Liu X, Li C, Huang Q. J Exp Clin Cancer Res; 2019 Nov 09; 38(1):461. PubMed ID: 31706322 [Abstract] [Full Text] [Related]
2. RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin. Shrestha A, Mehdizadeh Gohari I, McClane BA. mBio; 2019 Dec 17; 10(6):. PubMed ID: 31848291 [Abstract] [Full Text] [Related]
3. Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells. Sun W, Wu X, Gao H, Yu J, Zhao W, Lu JJ, Wang J, Du G, Chen X. Free Radic Biol Med; 2017 Jul 17; 108():433-444. PubMed ID: 28414098 [Abstract] [Full Text] [Related]
4. Emodin induced necroptosis in the glioma cell line U251 via the TNF-α/RIP1/RIP3 pathway. Zhou J, Li G, Han G, Feng S, Liu Y, Chen J, Liu C, Zhao L, Jin F. Invest New Drugs; 2020 Feb 17; 38(1):50-59. PubMed ID: 30924024 [Abstract] [Full Text] [Related]
5. PI3K mediates tumor necrosis factor induced-necroptosis through initiating RIP1-RIP3-MLKL signaling pathway activation. Hu S, Chang X, Zhu H, Wang D, Chen G. Cytokine; 2020 May 17; 129():155046. PubMed ID: 32114297 [Abstract] [Full Text] [Related]
6. Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice. Marunouchi T, Nishiumi C, Iinuma S, Yano E, Tanonaka K. Eur J Pharmacol; 2021 May 05; 898():173987. PubMed ID: 33640405 [Abstract] [Full Text] [Related]
7. Resveratrol inhibits necroptosis by mediating the TNF-α/RIP1/RIP3/MLKL pathway in myocardial hypoxia/reoxygenation injury. Hu Y, Pan H, Peng J, He J, Tang M, Yan S, Rong J, Li J, Zheng Z, Wang H, Liu Y, Zhong X. Acta Biochim Biophys Sin (Shanghai); 2021 Mar 26; 53(4):430-437. PubMed ID: 33686403 [Abstract] [Full Text] [Related]
8. Synthesis and biological evaluation of celastrol derivatives as potential anti-glioma agents by activating RIP1/RIP3/MLKL pathway to induce necroptosis. Feng Y, Wang W, Zhang Y, Fu X, Ping K, Zhao J, Lei Y, Mou Y, Wang S. Eur J Med Chem; 2022 Feb 05; 229():114070. PubMed ID: 34968902 [Abstract] [Full Text] [Related]
9. GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma. Liu M, Li H, Yang R, Ji D, Xia X. J Neuroinflammation; 2022 Oct 26; 19(1):262. PubMed ID: 36289519 [Abstract] [Full Text] [Related]
10. Extracts derived from a traditional Chinese herbal formula triggers necroptosis in ectocervical Ect1/E6E7 cells through activation of RIP1 kinase. Chen X, Hu X, Liu L, Liang X, Xiao J. J Ethnopharmacol; 2019 Jul 15; 239():111922. PubMed ID: 31034957 [Abstract] [Full Text] [Related]
11. Necrostatin-1 Protects Against Paraquat-Induced Cardiac Contractile Dysfunction via RIP1-RIP3-MLKL-Dependent Necroptosis Pathway. Zhang L, Feng Q, Wang T. Cardiovasc Toxicol; 2018 Aug 15; 18(4):346-355. PubMed ID: 29299822 [Abstract] [Full Text] [Related]
12. Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1/RIP3 necrosome formation. Lu B, Gong X, Wang ZQ, Ding Y, Wang C, Luo TF, Piao MH, Meng FK, Chi GF, Luo YN, Ge PF. Acta Pharmacol Sin; 2017 Nov 15; 38(11):1543-1553. PubMed ID: 28816233 [Abstract] [Full Text] [Related]
13. Coordinated ubiquitination and phosphorylation of RIP1 regulates necroptotic cell death. de Almagro MC, Goncharov T, Izrael-Tomasevic A, Duttler S, Kist M, Varfolomeev E, Wu X, Lee WP, Murray J, Webster JD, Yu K, Kirkpatrick DS, Newton K, Vucic D. Cell Death Differ; 2017 Jan 15; 24(1):26-37. PubMed ID: 27518435 [Abstract] [Full Text] [Related]
14. Nuclear translocation of MLKL enhances necroptosis by a RIP1/RIP3-independent mechanism in H9c2 cardiomyoblasts. Ino S, Yano T, Kuno A, Tanno M, Kouzu H, Sato T, Yamashita T, Ohwada W, Osanami A, Ogawa T, Toda Y, Shimizu M, Miura T. J Pharmacol Sci; 2023 Feb 15; 151(2):134-143. PubMed ID: 36707179 [Abstract] [Full Text] [Related]
15. RIP3 AND pMLKL promote necroptosis-induced inflammation and alter membrane permeability in intestinal epithelial cells. Negroni A, Colantoni E, Pierdomenico M, Palone F, Costanzo M, Oliva S, Tiberti A, Cucchiara S, Stronati L. Dig Liver Dis; 2017 Nov 15; 49(11):1201-1210. PubMed ID: 28844856 [Abstract] [Full Text] [Related]
16. Panax notoginseng Saponins Protect Brain Microvascular Endothelial Cells against Oxygen-Glucose Deprivation/Resupply-Induced Necroptosis via Suppression of RIP1-RIP3-MLKL Signaling Pathway. Hu Y, Lei H, Zhang S, Ma J, Kang S, Wan L, Li F, Zhang F, Sun T, Zhang C, Li W. Neurochem Res; 2022 Nov 15; 47(11):3261-3271. PubMed ID: 35904697 [Abstract] [Full Text] [Related]
17. RIP1/RIP3/MLKL mediates dopaminergic neuron necroptosis in a mouse model of Parkinson disease. Lin QS, Chen P, Wang WX, Lin CC, Zhou Y, Yu LH, Lin YX, Xu YF, Kang DZ. Lab Invest; 2020 Mar 15; 100(3):503-511. PubMed ID: 31506635 [Abstract] [Full Text] [Related]
18. Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway. Xin J, You D, Breslin P, Li J, Zhang J, Wei W, Cannova J, Volk A, Gutierrez R, Xiao Y, Ni A, Ng G, Schmidt R, Xia Z, Pan J, Chen H, Patel MM, Kuo PC, Nand S, Kini AR, Zhang J, Chen J, Zhu J, Zhang J. Leukemia; 2017 May 15; 31(5):1154-1165. PubMed ID: 27748372 [Abstract] [Full Text] [Related]
19. Inhibition of HSP90α protects cultured neurons from oxygen-glucose deprivation induced necroptosis by decreasing RIP3 expression. Wang Z, Guo LM, Wang Y, Zhou HK, Wang SC, Chen D, Huang JF, Xiong K. J Cell Physiol; 2018 Jun 15; 233(6):4864-4884. PubMed ID: 29334122 [Abstract] [Full Text] [Related]
20. RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review). Liu Y, Liu T, Lei T, Zhang D, Du S, Girani L, Qi D, Lin C, Tong R, Wang Y. Int J Mol Med; 2019 Sep 15; 44(3):771-786. PubMed ID: 31198981 [Abstract] [Full Text] [Related] Page: [Next] [New Search]